Health Products

Archivé – Levemir insulin: Lot numbers XZF0036, XZF0037, and XZF0038

· Published by Health Canada · Official notice

Details

Alert type: Foreign Product Alert (FPA)
Category: Drugs
Issue: Important Safety Information, Quality
Audience: General Public, Healthcare Professionals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Introduction

These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.

Details

Source of alert

U.S. Food and Drug Administration (FDA)

Product name

Levemir insulin: Lot numbers XZF0036, XZF0037, and XZF0038

Manufacturer / Place of origin

Novo Nordisk Inc., Princeton, New Jersey, USA

Product description

Levemir insulin is used to treat type 1 diabetes in adults and children, and type 2 diabetes in adults who require long-acting insulin to control high blood sugar.

The product, which is administered by injection, is packaged in 10 ml vials.

Reason for warning

The FDA warned consumers not to buy or use three lots of Levemir insulin vials (lot numbers XZF0036, XZF0037, and XZF0038). These lots, which were reported stolen in the U.S., have reappeared for sale on the U.S. market. The three lots, totalling 129,000 vials, may not have been stored and handled properly and may pose a serious risk to health.

Possible side effects

The FDA has received one report of a patient who suffered an adverse event due to poor control of blood sugar levels after using a vial from one of these three lots.

What you should do

The FDA is advising U.S. consumers to:

  1. Check your personal supply of insulin to determine if you have Levemir insulin vial from one of the following lots: XZF0036, XZF0037, and XZF0038. Patients can locate the lot number on the side of the box of insulin and also on the side of the vial.
  2. Do not use your Levemir insulin if it is from one of these lots. Replace it with a vial of Levemir insulin from another lot. If you must switch to another brand of insulin for any reason, first contact your healthcare provider as another insulin product may require adjustments in dosing.
  3. Always visually inspect your insulin before using it. Levemir is a clear and colorless solution.
  4. Contact the Novo Nordisk Customer Care Center at 800-727-6500 for what to do with vials from these lots or if you have any other questions.

Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.

Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.

Background

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.

Report a health or safety concern

  • Call toll-free at 1-866-234-2345.
  • Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime